Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1

Conditions

Smoking Cessation 1Prostatic Neoplasms 1Prostate Cancer Prevention 1Lung Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × sulforaphane × Clear all
NCT03232138 2024-12-17

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

University of Pittsburgh

Phase 2 Completed
43 enrolled 19 charts
Thoracic

Lung Neoplasms, Smoking Cessation

NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed
98 enrolled 10 charts
Genitourinary

Prostate Cancer Prevention

NCT01228084 2017-04-28

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡